Bradford Crutchfield, Chief Commercial Officer at 10x Genomics, Inc. (TXG), sold 29,397 shares at $118.32 ($3.5M) on 2022-01-12, disclosed to the SEC on 2022-01-14.
Open-market sale of $3.5M TXG by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $117.53 | 6,195 | $728K | 20.9% |
| 2 | $117.53 | 6,195 | $728K | 20.9% |
| 3 | $118.32 | 5,185 | $613K | 17.6% |
| 4 | $118.32 | 5,185 | $613K | 17.6% |
| 5 | $119.28 | 1,017 | $121K | 3.5% |
| 6 | $119.28 | 1,017 |
| $121K |
| 3.5% |
| 7 | $120.93 | 1,100 | $133K | 3.8% |
| 8 | $121.77 | 3,200 | $390K | 11.2% |
| 9 | $122.94 | 100 | $12K | 0.4% |
| 10 | $123.53 | 100 | $12K | 0.4% |
| 11 | $124.44 | 100 | $12K | 0.4% |
| 12 | $125.00 | 3 | $375 | 0.0% |
| Total | $118.58 avg | 29,397 | $3.5M | 100% |
| Filing → |
| TXG | SELL | 2022-02-24 | $23K | — | Filing → |
| TXG | SELL | 2022-02-17 | $1.6M | — | Filing → |
| TXG | SELL | 2021-12-15 | $4.2M | — | Filing → |